31 Mar 2023
Assets36.54
Total Income56.61
EBITDA-0.99
Profit After Tax-5.73
NET Worth5.96
Reserves and Surplus4.96
Total Borrowing15.31
At a glance
Updated 2026-08-24The shares listed at ₹99.50, a 10.56% move from the issue price. Modern Diagnostic is a SME IPO with an issue size of ₹36.89 crore, proposed for listing on BSE SME. The offer opens on 31st Dec 2025 and closes on 2nd Jan 2026. The issue structure includes a fresh issue of ₹35.04 crore. The current listing schedule points to 7th Jan 2026.
Issue details
Listing atBSE SME
Issue typeBook Build Issue
Issue size₹36.89 Cr
Fresh issue₹35.04 Cr
Face value₹10
Price band₹85.00–₹90.00
Allotment5th Jan 2026
Listing7th Jan 2026
Listing performance
Full performance ↗Issue price₹90.00
Listing price₹99.50
Current price—
Listing gain10.56%
Current return—
Price progressionIssue → Listing → Current
Grey market
GMP page ↗Latest GMP₹14.00
GMP / upper price15.56%
Est. listing₹104.00
GMP is unofficial sentiment data, not an exchange price.
Timeline
Opens31st Dec 2025
Closes2nd Jan 2026
Allotment5th Jan 2026
Refund6th Jan 2026
Demat6th Jan 2026
Listing7th Jan 2026
Subscription demand
Full bidding ↗Total376.90×
Lot size
| Investor | Lots | Shares | Amount |
|---|---|---|---|
| Minimum Bid | 1 | 3200 | ₹288,000 |
Company
Incorporated1985
Use of proceeds
| Object | Amount |
|---|---|
| Funding capital expenditure for purchase of medical Equipments for diagnostic centre and laboratories | ₹20.69 Cr |
| Funding working capital requirements of the Company | ₹8.00 Cr |
| Repayment of certain outstanding borrowings availed by the Company | ₹1.00 Cr |
| General Corporate Expenses | ₹3.33 Cr |
| Issue Expenses | ₹3.87 Cr |
| Total | ₹36.89 Cr |
Financials
Full financials ↗31 Mar 2024
Assets49.49
Total Income68.67
EBITDA11.05
Profit After Tax5.79
NET Worth11.76
Reserves and Surplus10.76
Total Borrowing20.46
31 Mar 2025
Assets64.57
Total Income78.80
EBITDA17.96
Profit After Tax8.97
NET Worth20.73
Reserves and Surplus9.73
Total Borrowing22.09
30 Jun 2025
Assets77.86
Total Income22.67
EBITDA5.86
Profit After Tax3.00
NET Worth23.72
Reserves and Surplus12.72
Total Borrowing30.38
Trend chart₹ crore
KPIs
| KPI | Mar 31, 2025 |
|---|---|
| ROE | 55.21% |
| ROCE | 36.18% |
| Debt / Equity | 1.07% |
| RoNW | 43.27% |
| PAT Margin | 11.51% |
| EBITDA Margin | 23.04% |
| Price to Book Value | 4.78 |
Valuation & shareholding
Pre-IPO EPS8.15
Post-IPO EPS7.94
Pre-IPO P/E11.04
Post-IPO P/E11.33
Promoter holding pre99.99%
Promoter holding post72.85%
Market cap₹135.89 Cr.
Issue expenses
| Expense | Amount |
|---|---|
| Funding capital expenditure for purchase of medical Equipments for diagnostic centre and laboratories | ₹20.69 Cr |
| Funding working capital requirements of the Company | ₹8.00 Cr |
| Repayment of certain outstanding borrowings availed by the Company | ₹1.00 Cr |
| General Corporate Expenses | ₹3.33 Cr |
| Issue Expenses | ₹3.87 Cr |
| Total | ₹36.89 Cr |
Registrar & lead managers
Registrar
MUFG Intime India Pvt.Ltd.Lead managers
- Beeline Capital Advisors Pvt.Ltd.
Data is reconciled from multiple public IPO sources. Official exchange filings and offer documents remain the source of truth. Last verified 2026-08-24.